Electrotrichogenesis: further evidence of efficacy and safety on extended use.
These data represent a subset of data from the original 36-week study conducted by Maddin et al., which was in itself a preliminary study of a pulsed electrical stimulation device in male subjects alone. The extension phase of this study, which is summarized here, was undertaken to gather data on longer-term efficacy and safety and to study clinical effects in control subjects who were then switched to active treatment. Thirteen subjects had active treatment for 70 weeks, and 14 subjects were included in the crossover group, which had sham treatment for 36 weeks followed by active treatment for 30 additional weeks. On average, terminal hair counts increased from 82 to 276 in the active treatment group. Among those in the crossover group, a mild increase, from 124 to 160, was observed during the sham treatment period and a more notable increase, from 160 to 249, occurred during the subsequent active treatment period. The results presented here provide evidence of the efficacy and safety of this device during extended use; however, the generalizability of these findings is limited by the small subset of subjects for whom complete data are available.
Maddin
W S
WS
Department of Medicine, University of British Columbia Faculty of Medicine, Vancouver, Canada.
Amara
I
I
Sollecito
W A
WA
D000328:Adult; D000505:Alopecia / Q000628:therapy*; D004599:Electric Stimulation Therapy; D006801:Humans; D008297:Male; D013997:Time Factors